Central Neurogenic Hyperventilation


Risk

  • True CNH is exceedingly rare; the exact incidence is unknown.

  • In pts with neurologic injury, it is most often associated with pulm dysfunction or shunting (aspiration, pneumonia, pulm edema, and baseline disease).

  • Primarily seen in comatose pts.

  • No association with age or gender.

Overview

  • A diagnosis of exclusion in neurologic disorders and in cases of hyperventilation; life-threatening causes of hyperventilation (hypoxemia, ischemic bowel, and acidosis) must be ruled out.

  • Primary diagnostic criteria are hyperventilation that persists during sleep; low PaCO 2 , high PaO 2 , and absence of drug or metastatic causes.

  • Associated primarily with brainstem inflammation and brainstem tumors with inconsistent involvement of midbrain, pons, and/or medulla.

  • CNS lymphomas and astrocytomas are the most common tumor types with gliomas, lymphomatoid granulomatosis, and medulloblastoma; also reported in metastatic tumors.

  • May result from seizure activity that stimulates the ventilatory response.

  • May be associated with acute intermittent porphyria.

  • Effects of GA unknown.

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here